Investors Still Waiting For A Pull Back In Zhende Medical Co., Ltd. (SHSE:603301)
With a price-to-earnings (or "P/E") ratio of 43.5x Zhende Medical Co., Ltd. (SHSE:603301) may be sending bearish signals at the moment, given that almost half of all companies in China have P/E ratios
Zhende Medical (603301.SH) announced first-quarter results, net profit of 73.3976 million yuan, a year-on-year decrease of 49.89%
Zhende Medical (603301.SH) released its report for the first quarter of 2024. The company's revenue was 964 million yuan...
Zhende Medical (603301.SH): The ban on 39.2465 million restricted shares was lifted on March 26
Gelonghui March 20 丨 Zhende Medical (603301.SH) announced that the total number of shares in circulation in the company's current stock listing was 39.2465 million shares. The stock listing and circulation date is March 26, 2024.
Investors Could Be Concerned With Zhende Medical's (SHSE:603301) Returns On Capital
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Amongst other things, we'll want to see two things; firstly, a growing return on
Some directors and supervisors of Zhende Medical (603301.SH) completed a total reduction of 65,800 shares
Zhende Medical (603301.SH) announcement, Xu Dasheng, director and deputy general manager of the company, Zhang Xiantao, chairman of the supervisory board...
Zhende Medical Co., Ltd. (SHSE:603301) Has A ROE Of 11%
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business.
Zhende Healthcare (603301.SH) released the first three quarter results, net profit of 301 million yuan, a year-on-year decrease of 33.96%
Zhende Medical (603301.SH) released its report for the third quarter of 2023. The company achieved operating income of 3 in the first three quarters...
Zhende Medical (603301.SH) plans to pay 7.5 yuan for every 10 shares for the half-year, excluding interest on October 31
Zhende Medical (603301.SH) announced that the company plans to distribute every 10 shares to all shareholders for the semi-annual period of 2023.
Declining Stock and Decent Financials: Is The Market Wrong About Zhende Medical Co., Ltd. (SHSE:603301)?
Zhende Medical (SHSE:603301) has had a rough three months with its share price down 14%. However, the company's fundamentals look pretty decent, and long-term financials are usually aligned with fut
Zhende Medical (603301.SH) released semi-annual results, with net profit of 237 million yuan, down 12.6% from the previous year, and plans to distribute 7.5 yuan in 10
Zhende Medical (603301.SH) disclosed the 2023 semi-annual report. The company achieved revenue of 23.0 during the reporting period...
Private Companies Are Zhende Medical Co., Ltd.'s (SHSE:603301) Biggest Owners and Were Hit After Market Cap Dropped CN¥480m
Key Insights Zhende Medical's significant private companies ownership suggests that the key decisions are influenced by shareholders from the larger public The largest shareholder of the company is
Zhende Medical's (SHSE:603301) Returns On Capital Not Reflecting Well On The Business
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Typically, we'll want to notice a trend of growing return on capital employed (ROCE) and alongside that,
Zhende Healthcare (603301.SH): Some directors and supervisors plan to reduce their holdings by no more than 165,200 shares
According to the Zhitong Finance App, Zhende Healthcare (603301.SH) announced that Xu Dasheng, director and deputy general manager of the company, Zhang Xiutao, chairman of the board of supervisors, Hu Xiuyuan, and financial director Jin Haiping plan to reduce the company's total share holdings by no more than 165,200 shares through centralized bidding transactions, that is, no more than 25% of the total number of individual shares held, accounting for no more than 0.0620% of the company's total share capital.
Zhende Medical's (SHSE:603301) Five-year Total Shareholder Returns Outpace the Underlying Earnings Growth
It hasn't been the best quarter for Zhende Medical Co., Ltd. (SHSE:603301) shareholders, since the share price has fallen 17% in that time. On the bright side the share price is up over the last ha
Zhende Medical Co., Ltd.'s (SHSE:603301) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Zhende Medical (SHSE:603301) has had a rough three months with its share price down 10%. However, stock prices are usually driven by a company's financials over the long term, which in this case loo
Some Investors May Be Worried About Zhende Medical's (SHSE:603301) Returns On Capital
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other things, we'll want to see two things; firstly, a growing return on capital employe
Zhende Medical Co., Ltd.'s (SHSE:603301) Market Cap Dropped CN¥386m Last Week; Private Companies Bore the Brunt
A look at the shareholders of Zhende Medical Co., Ltd. (SHSE:603301) can tell us which group is most powerful. And the group that holds the biggest piece of the pie are private companies with 54% own
Zhende Medical (SHSE:603301) Seems To Use Debt Quite Sensibly
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it seems
Zhende Medical (SHSE:603301) Could Be Struggling To Allocate Capital
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically, we'll want to notice a trend of growing return on capital employed (ROCE) and al
Zhende Medical's (SHSE:603301) Earnings Growth Rate Lags the 55% CAGR Delivered to Shareholders
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But if you buy shares in a really great company, you can more than double your money. To wit, the Zhende M
No Data